The Burrill Report


The Burrill Report (February 28, 2011): A Supply Chain Reaction (.MP3,10.91 Mb)

As the pharmaceutical industry moves away from an era defined by blockbusters, its products are becoming more diverse and the markets it serves global. While companies have put great investment into rebuilding their pipelines and expanding into emerging markets, a new report from PwC says they have neglected the implications these changes will have on manufacturing, distribution, and other links in the supply chain. We spoke to Wynn Bailey, partner in the pharmaceuticals and life sciences advisory practice of PwC, about the changes taking place in the industry, how prepared companies are for the downstream consequences of them, and the choices they will face in the years ahead.











February 25, 2011
http://www.burrillreport.com/article-a_supply_chain_reaction.html